A trial to study effects of early anticoagulation resumption with apixaban on the acute stroke patients

Trial Profile

A trial to study effects of early anticoagulation resumption with apixaban on the acute stroke patients

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Apr 2016

At a glance

  • Drugs Apixaban (Primary)
  • Indications Stroke
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 05 Apr 2016 New trial record
    • 19 Feb 2016 Results presented at the 41st International Stroke Conference
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top